{"schema_version":"1","generated_at":"2026-10-28T20:50:54.209Z","data_as_of":null,"url":"https://www.findmykol.com/kol/carrie-lee","json_url":"https://www.findmykol.com/kol/carrie-lee/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"carrie-lee","name":"Carrie Lee","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of North Carolina at Chapel Hill","institution_url":"https://www.findmykol.com/institution/university-of-north-carolina-at-chapel-hill","city":"Chapel Hill","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1538281928","orcid":"0000-0003-4786-3834","openalex":"A5062627792"},"summary":"Carrie Lee is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 102 publications with 4,062 citations (h-index 29); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":102,"cited_by_count":4062,"h_index":29,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06896162","title":"PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06896162","trial_url":"https://www.findmykol.com/trial/NCT06896162"},{"nct":"NCT01726738","title":"LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT01726738","trial_url":"https://www.findmykol.com/trial/NCT01726738"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Stryker Corporation","program_year":2023,"amount_usd":45.63,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1538281928"},{"payer":"PFIZER INC.","program_year":2022,"amount_usd":27.5,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1538281928"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1538281928","source":"payments"},"funding":{"award_count":3,"fiscal_years":{"first":2021,"last":2026},"rows_total":11,"shown":3,"withheld":8,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"UG1CA286949","title":"Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)","fiscal_year":2026,"amount_usd":"1046336","organization":"UNIV OF NORTH CAROLINA CHAPEL HILL","source_url":"https://reporter.nih.gov/quickSearch/UG1CA286949"},{"project":"P30CA016086","title":"Clinical Protocol and Data Management","fiscal_year":2026,"amount_usd":"916015","organization":"UNIV OF NORTH CAROLINA CHAPEL HILL","source_url":"https://reporter.nih.gov/quickSearch/P30CA016086"},{"project":"UG1CA286949","title":"Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)","fiscal_year":2025,"amount_usd":"875106","organization":"UNIV OF NORTH CAROLINA CHAPEL HILL","source_url":"https://reporter.nih.gov/quickSearch/UG1CA286949"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Genotypic testing improves detection of antiviral resistance in human herpes simplex virus","year":2023,"journal":"Journal of Clinical Virology","source_url":"https://doi.org/10.1016/j.jcv.2023.105554","status":"verified"},{"title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial","year":2022,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(21)00658-6","status":"verified"},{"title":"Temporal Control of the WNT Signaling Pathway During Cardiac Differentiation Impacts Upon the Maturation State of Human Pluripotent Stem Cell Derived Cardiomyocytes","year":2022,"journal":"Frontiers in Molecular Biosciences","source_url":"https://doi.org/10.3389/fmolb.2022.714008","status":"verified"},{"title":"The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma","year":2022,"journal":"BMC Cancer","source_url":"https://doi.org/10.1186/s12885-021-08908-z","status":"verified"},{"title":"Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes","year":2021,"journal":"Cardiovascular Research","source_url":"https://doi.org/10.1093/cvr/cvab311","status":"verified"}],"source":"works"},"contact":{"address_1":"DIVISION OF ONCOLOGY UNC CHAPEL HL","address_2":"3009 OLD CLINIC BLDG. CB#7305","city":"Chapel Hill","state":"NC","zip":"275990001","phone":"919-843-6281","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1538281928","source":"identity"},"similar":[{"name":"Lisa Carey","slug":"lisa-carey","institution":"University of North Carolina at Chapel Hill","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/lisa-carey","json_url":"https://www.findmykol.com/kol/lisa-carey/profile.json"},{"name":"Diana Perkins","slug":"diana-perkins","institution":"University of North Carolina at Chapel Hill","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/diana-perkins","json_url":"https://www.findmykol.com/kol/diana-perkins/profile.json"},{"name":"Douglas Drossman","slug":"douglas-drossman","institution":"University of North Carolina at Chapel Hill","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/douglas-drossman","json_url":"https://www.findmykol.com/kol/douglas-drossman/profile.json"},{"name":"Michael Knowles","slug":"michael-knowles","institution":"University of North Carolina at Chapel Hill","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/michael-knowles","json_url":"https://www.findmykol.com/kol/michael-knowles/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":8,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}